You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

METAVIR

Showing 1 - 25 of 111
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Alpha1-Antitrypsin Deficiency Trial (Fazirsiran Injection, Placebo)

Not yet recruiting
  • Alpha1-Antitrypsin Deficiency
  • Fazirsiran Injection
  • Placebo
  • (no location specified)
Feb 2, 2023

Advanced Liver Fibrosis Using Non-invasive Tests in Primary Care

Not yet recruiting
  • Hepatic Fibrosis
    • (no location specified)
    Oct 31, 2023

    Hepatic Fibrosis on Hepatic Steatosis Using Ultrasound

    Not yet recruiting
    • Hepatic Steatosis
    • +2 more
      • Seoul, Korea, Republic of
        Asan Medical Center
      May 21, 2023

      Hepatic Cirrhosis, Liver Fibrosis Trial in San Antonio (BMS-986263, Placebo)

      Completed
      Has Results
      • Hepatic Cirrhosis
      • Liver Fibrosis
      • San Antonio, Texas
        The Texas Liver Institute
      Feb 3, 2022

      Chronic Liver Disease and Cirrhosis Trial in Cairo (Vitamin D)

      Completed
      • Chronic Liver Disease and Cirrhosis
      • Vitamin D
      • Cairo, Egypt
      • +1 more
      Feb 4, 2023

      Alpha 1-Antitrypsin Deficiency Trial in Austria, Germany, United Kingdom (ARO-AAT Injection)

      Active, not recruiting
      • Alpha 1-Antitrypsin Deficiency
      • ARO-AAT Injection
      • Vienna, Austria
      • +3 more
      Apr 28, 2022

      Hepatitis C Trial (Zinc Supplement)

      Not yet recruiting
      • Hepatitis C
      • Zinc Supplement
      • (no location specified)
      Jul 16, 2022

      Predict Antiviral Therapy in Gray Zone of Chronic Hepatitis B

      Not yet recruiting
      • Hepatitis B, Chronic
      • Exposure factors
      • (no location specified)
      Sep 10, 2023

      Liver Cirrhosis, Hepatitis C, Chronic, Epigenetic Disorder Trial in Guadalajara, Mexico City (Prolonged-Release Pirfenidone)

      Recruiting
      • Liver Cirrhosis
      • +2 more
      • Prolonged-Release Pirfenidone
      • Guadalajara, Jalisco, Mexico
      • +1 more
      Sep 13, 2022

      Development of Novel MRI Methods for Detecting, Discriminating,

      Recruiting
      • Liver Fibrosis
      • Non-Contrast Magnetic Resonance Imaging
      • Cincinnati, Ohio
        Cincinnati Children's Hospital Medical Center
      Jun 10, 2021

      Sleep Apnoea Syndrome and Hepatocellular Carcinoma

      Withdrawn
      • Sleep Apnea, Obstructive
      • +2 more
      • Nocturnal oximetry
      • La Tronche, Rhones-Alpes, France
        Minovés-Kotzki
      May 17, 2022

      Cirrhosis, Liver Diseases Trial in Guangzhou (ultrasound viscoelasticity)

      Recruiting
      • Cirrhosis
      • Liver Diseases
      • ultrasound viscoelasticity
      • Guangzhou, Guangdong, China
        The department of Ultrasound, the third affiliated hospital of S
      Sep 1, 2021

      Liver Fibroses, Cirrhosis Trial in Boston, Dallas (Atorvastatin 20mg, Placebo)

      Not yet recruiting
      • Liver Fibroses
      • Cirrhosis
      • Atorvastatin 20mg
      • Placebo
      • Boston, Massachusetts
      • +1 more
      Feb 8, 2022

      Surgery, Obesity, NASH - Nonalcoholic Steatohepatitis Trial in Lille (Lifestyle therapy, Bariatric surgery)

      Recruiting
      • Surgery
      • +3 more
      • Lifestyle therapy
      • Bariatric surgery
      • Lille, France
        Hôpital Claude Huriez, CHRU
      Apr 20, 2021

      Alpha 1-Antitrypsin Deficiency Trial in Worldwide (belcesiran, Placebo)

      Recruiting
      • Alpha 1-Antitrypsin Deficiency
      • Melbourne, Australia
      • +15 more
      Aug 10, 2022

      Non-alcoholic Fatty Liver Disease (NAFLD) Trial in Frankfurt am Main (Controlled Attenuation Parameter (CAP), Echosens, Paris,

      Completed
      • Non-alcoholic Fatty Liver Disease (NAFLD)
      • Controlled Attenuation Parameter (CAP), Echosens, Paris, France
      • FibroScan, Echosens, Paris, France
      • Frankfurt am Main, Hessen, Germany
        University Hospital Frankfurt
      Feb 1, 2021

      Alpha 1-Antitrypsin Deficiency Trial in Worldwide (ARO-AAT Injection, Placebo)

      Active, not recruiting
      • Alpha 1-Antitrypsin Deficiency
      • Fazisiran Injection
      • Placebo
      • Birmingham, Alabama
      • +20 more
      Nov 3, 2022

      Disease Loads and Status of Treatment

      Recruiting
      • Chronic Hepatitis B
      • +2 more
      • Prospective serological assays
      • Retrospective serological assays
      • Taipei City, Taiwan
        National Taiwan University Hospital
      Feb 28, 2022

      Steatohepatitis in Chronic Hepatitis B

      Completed
      • Fatty Liver
      • Chronic Hepatitis b
      • Antiviral Agents
      • Bangkoknoi, Bangkok, Thailand
        Faculty of Medicine Siriraj Hospital
      Mar 30, 2022

      Hepatitis C Trial in Malaysia, Thailand (sofosbuvir + ravidasvir)

      Active, not recruiting
      • Hepatitis C
      • sofosbuvir + ravidasvir
      • Johor Bahru, Johor, Malaysia
      • +12 more
      Jan 18, 2021

      Liver Fibrosis in Zambian HIV-HBV Co-infected Patients

      Active, not recruiting
      • Human Immunodeficiency Virus
      • +6 more
      • Anti-HIV Agents
      • Lusaka, Zambia
        Centre for Infectious Disease Research in Zambia (CIDRZ)
      Jun 1, 2022

      Hepatitis C Trial (boceprevir, PegIFN-2b, RBV)

      Completed
      Has Results
      • Hepatitis C
      • (no location specified)
      Aug 6, 2018

      Liver and Spleen Stifness in Adult Gaucher's Disease Using

      Unknown status
      • Gaucher Disease
      • +2 more
        • Afula, Tsafon, Israel
          HaEmek Medical Center
        Feb 11, 2020

        Psoriasis Trial in Cleveland (Fibroscan and Fibrosure)

        Withdrawn
        • Psoriasis
        • Fibroscan and Fibrosure
        • Cleveland, Ohio
          University Hospitals Cleveland Medical Center
        Jul 22, 2020

        Liver Fibrosis, Chronic Liver Disease Trial in Mexico City (Pirfenidone, Standard of care)

        Unknown status
        • Liver Fibrosis
        • Chronic Liver Disease
        • Mexico City, Mexico
          Liver Clinic 1
        Sep 19, 2019